- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
China is poised to significantly expand its butadiene production capacity by 2030, backed by strong demand for butadiene derivatives such as acrylonitrile butadiene styrene (ABS) and synthetic rubbers from the automotive and tire industries. Accounting for over 50% of the expected capacity additions worldwide by 2030, China is positioning itself as the dominant player in […]
K2 Black Panther deal with Poland to strengthen South Korea’s position in European defense market, says GlobalData
South Korea’s ambitions to become a major global defense exporter have taken a significant leap forward with the recent announcement of a $6.5 billion contract to supply 180 K2 Black Panther main battle tanks to Poland. The deal confirms Seoul as a trusted supplier of modern, North Atlantic Treaty Organization (NATO)‑compatible equipment at a time […]
US Open (Golf) generates estimated $39 million in sponsorship revenue for 2025 edition, reveals GlobalData
Seven brands sponsored the 2025 edition of the US Open (Golf), with American Express, Rolex, and Lexus entering into substantial agreements estimated at an annual value of $6.25 million each. Overall, the annual sponsorship revenue for the 2025 edition of the tournament is estimated to be $39 million, according to GlobalData, a leading data and […]
CDC’s vaccine advisory committee overhaul raises concerns for vaccine oversight, says GlobalData
On 9 June 2025, in a significant and controversial shake-up, US Secretary of Health and Human Services Robert F. Kennedy Jr. dismissed all 17 members of the Centers for Disease Control and Prevention (CDC) Advisory Committee for Immunization Practices (ACIP), the body responsible for advising the federal government on vaccine safety. This decision has raised […]
Top 25 global banks see 32% increase in MCap in Q2 2025, reveals GlobalData
JPMorgan Chase retains top spot European banks post strong gains The aggregate market capitalization (MCap) of the top 25 global banks increased by 31.9% year-on-year (YoY), reaching $5.3 trillion in the second quarter (Q2) ended 30 June 2025, as continued central banks’ interest rate cuts and strong capital market activity led to a rise in […]
Hypersonic missiles to help Japan counter escalating security challenges in Indo-Pacific region, says GlobalData
The deployment of the Hyper Velocity Guided Projectile (HVGP) will be a significant shift in Japan’s defense strategy, which has historically committed to a purely defensive posture. Japan is now poised to integrate this hypersonic missile into its force structure to conduct offensive operations when required. The advancements in missile technology by China and North […]
Multiple sclerosis market to grow to $25.9 billion across 7MM by 2034, forecasts GlobalData
The multiple sclerosis (MS) disease-modifying therapy (DMT) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 1.7% from $22.0 billion in 2024 to $25.9 billion in 2034, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Multiple Sclerosis: Seven Market Drug Forecast […]
Challenges mount for big pharma in China as vaccine sales plummet, says GlobalData
Multinational pharmaceutical companies (MNCs) are facing significant challenges in China’s vaccine market, as regulatory scrutiny, domestic competition, and changing consumer behaviors disrupt a once-thriving sector. Major players like Merck & Co. and GSK are re-evaluating their strategies in light of these developments, says GlobalData, a leading data and analytics company. GlobalData’s Q2 2025 Emerging Market […]
CKD anemia market to reach $5.3 billion across 7MM by 2034, forecasts GlobalData
The chronic kidney disease (CKD) anemia market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 1.7% from $4.4 billion in 2024 to $5.3 billion in 2034, according to GlobalData, a leading data and analytics company. GlobalData’s latest report “Chronic Kidney Disease Anemia: Opportunity Assessment and […]
Vutrisiran to change ATTR-CM treatment paradigm in Europe, says GlobalData
Transthyretin amyloidosis (ATTR) is a protein conformational disorder caused by the build-up of transthyretin, the protein carrying thyroxine and retinol in the bloodstream. It can cause ATTR-cardiomyopathy (ATTR-CM) or ATTR-polyneuropathy (ATTR-PN). As effective treatments for ATTR-CM are still limited, Alnylam Pharmaceuticals’ drug vutrisiran is expected to change ATTR-CM treatment paradigm upon market launch in Europe, […]
Alzheimer’s drugs acquisition deal-making surges to $16.8 billion in 2025YTD, reveals GlobalData
Acquisitions involving Alzheimer’s disease innovator drugs surged in total deal value by more than 780%, increasing from $2 billion in 2022 to almost $18 billion in 2024. The momentum in acquisition activity continued into 2025, with the total deal value reaching $16.8 billion by May, highlighting Alzheimer’s disease as a key area of focus by […]
US tariffs could redirect manufacturing to Mexico rather than US, says GlobalData
The United States–Mexico–Canada Agreement (USMCA), effective July 1, 2020, modernizes the North American Free Trade Agreement (NAFTA) by updating trade, labor, environmental, and digital commerce regulations. A key feature is that USMCA-compliant goods are exempt from US tariffs, including those set for April 2, 2025. Compliance hinges on a significant portion of a product’s value […]
Nontuberculous mycobacteria market to reach $4.6 billion in 7MM in 2033, forecasts GlobalData
The nontuberculous mycobacteria (NTM) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 8.8% from $2.0 billion in 2023 to $4.6 billion in 2033, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Nontuberculous Mycobacteria (NTM): Opportunity Assessment and Forecast”, reveals that […]
Recycled aluminum will minimize impact of tariffs on 70 billion beverage cans sold in US in 2025, says GlobalData
On 3 June 2025, the US announced it would impose 50% tariffs on all steel and aluminum imports. This move represented an escalation compared to the 25% tariff previously imposed on such imports on 10 February 2025. These policies create challenges for US manufacturers and users of packaging made of imported steel and aluminum. However, […]
Diagnosed prevalent cases of multiple sclerosis to increase by 0.19% AGR in 7MM during 2024-34, forecasts GlobalData
The diagnosed prevalent cases of multiple sclerosis (MS) in the seven major markets (7MM*) are projected to increase from 1.61 million in 2024 to 1.64 million in 2034 at an annual growth rate (AGR) of negative 0.19%, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Multiple Sclerosis Epidemiology Analysis and Forecast to […]
UK health & beauty specialists lose out to discounters in value for money rankings, finds GlobalData
UK health & beauty specialists are struggling to compete with low-priced discounters, as consumers are not recognizing the additional value for money that comes from their better ranges, product quality, and service. With personal finances still recovering from the impact of inflationary pressure, consumers still prefer to shop at discounters for essentials, according to GlobalData, […]
Baxter’s Novum recall to impact infusion pump market sales, says GlobalData
Baxter’s recall of its Novum pump following a report of one serious injury related to under-infusion risks when the standby feature is used, and it has been determined that this risk increases when being used at higher flow rates. The recall may negatively affect sales in the infusion pump market, says GlobalData, a leading data […]
Japan cardiac marker tests market to reach $19 million by 2036, forecasts GlobalData
The increasing global burden of cardiovascular diseases (CVD), driven by lifestyle-related risk factors and limited access to early diagnostics, has accelerated the demand for advanced, data-driven medical solutions. Against this backdrop, Japan’s cardiac marker tests market value is forecast to reach $19 million by 2036, according to GlobalData, a leading data and analytics company. GlobalData’s […]
Yeztugo holds potential to address key unmet needs for PrEP usage including adherence issues, says GlobalData
The FDA has recently approved Gilead Sciences’ Yeztugo (lenacapavir) for the prevention of HIV infection. This is the first and only FDA approved HIV pre-exposure prophylaxis (PrEP) option offering six months of protection. The approval was based on the Phase III PURPOSE 1 and PURPOSE 2 trials that showed that more than 99% of participants […]
Australia nuclear imaging agents market to reach $30 million by 2036, forecasts GlobalData
With the rising incidence of prostate cancer in Australia, there is a growing need for accurate and timely diagnostic methods. As a result, the use of PET imaging and SPECT imaging agents is likely to rise over the next few years. The surge in precision diagnostics, bolstered by heightened awareness among healthcare professionals and proactive […]